Prof. Dr. Tilman Todenhöfer

School and Education

1992 - 2001 Secondary school Geschwister-Scholl Gymnasium Tübingen
2002 - 2004 School of Medicine University of Rostock 
2004 - 2009 School of Medicine University of Freiburg

Approbation

01.Dec.2009

Certified Urologist

07.Jul.2016

Appointment as Associate Professor (Habilitation), University of Tuebingen

22.Nov.2016

Appointment as Professor (apl. Professur) University of Tuebingen

11. Feb. 2019

Certification as Fellow of the European Board of Urology

03. Jun. 2017

Clinical Appointmens

01/2010 – 07/2016: Residency, Dept. of Urology, University Hospital Tübingen (Chairman Prof. A. Stenzl)
07/2016 – 01/2017 : Senior Physician, Dept. of Urology, University Hospital Tübingen
02/2017-03/2019: Faculty Member,
Dept. of Urology, University Hospital Tübingen
10/2017-03/2019: Head Clinical Trial Unit Dept. of Urology, University Hospital Tübingen
05/2019 shareholder, member of the team Studienpraxis Urologie Nürtingen

Postdoctoral Fellowship

05/2014-10/2015: Postdoctoral Research Fellow, University of British Columbia (Supervisors: Dr. Peter Black, Dr. Kim Chi) 

Role in Clinical Trials

Since 05/2012: Subinvestigator Clinic for Urology Tübingen
Since 06/2012: Subinvestigator Studienpraxis Urologie Nürtingen
10/2017-05/2019: head of the study center Clinic for Urology Tübingen

 GCP Training

Good Clinical Practice (GCP) 8-hours training 2/2012, 9/2014, 7/2017, CenTrial GmbH Tübingen

Role as reviewer for

BMC Urology, BMC Cancer, Biologics: Targets and Therapy, Carcinogenesis, Cancer Treatment Reviews, Clinical Interventions in Aging, Experimental and Clinical Endocrinology and Diabetes, European Urology, European Urology Focus, International Journal of Urology, Journal of Cancer Research and Clinical Oncology, Journal of Experimental and Clinical Cancer Research, Journal of Urology, Lancet Oncology, Molecular Cancer Research, Molecular Diagnosis & Therapy, Nature Reviews Urology, Oncotarget, PLOSone, Scientific Reports, Urologic Oncology, Radiotherapy & Oncology

Editor

Disease Markers (Impact 2.9)

Awards

2018: Best Poster Award Annual Meeting European Association of Urology (EAU) (Prostate Cancer)
2016: Maximilian Nitze Award German Society of Urology
2016: Best Poster Award Annual Meeting American Urologic Association (AUA) (Bladder Cancer)
2016: Best Poster Award Annual Meeting European Association of Urology (EAU) (CRPC)
2015: C.E. Alken Alken Award
2015: Research Award Canadian Urologic Association (CUA)
2015: Prostate Cancer Research Award German Society for Urology (DGU)
2014: Research Award Canadian Uroonocology Group (CUOG)
2014-2015: Scholarship German Cancer Foundation
2015 Best Poster Annual Meeting American Urologic Association (AUA) (Prostate Cancer)
2014 John Blandy Award British Association of Urological Surgeons
2013 Best Poster Annual Award Congress European Assocation of Urology (EAU) (Bladder Cancer)
2012 Best Poster Annual Meeting German Society for Urology (Prostate Cancer)
2012 Best Poster Annual Meeting German Society for Urology (Bladder Cancer)
2005-2009 Scholar German National Academic Foundation (Studienstiftung)

Memberships in Societies

Since 2016 Member Working Group Urologic Research (AuF) German Society for Urology
Since 2015 Expert Consultant Subcomittee for metastatic Prostate Cancer Multimedia Learning Committee Societe International de Urologie (SIU)